by Jordana Choucair | Mar 8, 2022 | Life Sciences
Bancel also said that Moderna is preparing to launch human trials by 2025 for vaccines targeting 15 viruses and other pathogens that “threaten global health.” He said the $300 million effort seeks to complete early dose and safety testing in case any of...
by Jordana Choucair | Mar 8, 2022 | Opioid/Substance Use Disorders
Three congressmen unveiled new bipartisan legislation that would permanently ban illicit versions of fentanyl. Thus far, Congress has not acted on a long-term solution over concerns that a permanent ban could stifle scientific research into fentanyl analogues and the...
by Jordana Choucair | Mar 7, 2022 | D.C. News
House Democrats plan to introduce a massive spending bill as soon as Tuesday that includes roughly $22.5 billion in COVID-19 relief money and about $10 billion to help bolster Ukraine. Since Republicans widely oppose additional COVID-19 relief funding, linking the two...
by Jordana Choucair | Mar 7, 2022 | Uncategorized
The FDA is getting closer to authorizing Novavax Inc.’s COVID-19 vaccine after the company said it fixed production issues that delayed its application. However, U.S. clearance for the protein-based shot is still a ways off given the FDA must review a lot of...
by Jordana Choucair | Mar 7, 2022 | Providers
A CVS Health/Harris Poll revealed that more than half of all Americans have directly felt the effects of health care worker shortages. Forty-five percent of the 2,000 adults polled February 10-15 said they had trouble scheduling appointments. Thirty-three percent said...
Recent Comments